drugset / Trial / NCT02005302

Optimizing Treatment Programs for Chronic Kidney Disease-mineral and Bone Disorder and Malnutrition

NCT02005302

RandomizedParallel-groupOpen-labelTreatment

Summary

Multi-center, prospective, randomized, controlled study to verify the clinical effectiveness of K / DOQI guidelines. The efficiency and safety of Vitamin D2 and low protein diet treatment for prevention and treatment of CKD-MBD and malnutrition in CKD3-5 (ND) patients.

Timeline

Start
2013-01
Primary completion
2015-12
Completion
2016-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator 1,25(OH)2 Vitamin D3 Unknown 0.25 ug Oral
Subject Ergocalciferol Small molecule 1.25 mg Oral